8 minute read
May 31, 2022
The 2021 New Drug Approvals for Immunological Diseases: Deep Dive
In 2021 the FDA approved four new drugs for various immunological diseases, including a molecular glue, the first drug approved for AAV in a decade, and a ROCK kinase inhibitor originally investigated for cancer. This article and slide deck explores each in more detail, including but not limited to their:
mechanisms of action
target rationale
disease context
original patents
key clinical data
industry history
Loading...